| Associated Podiatrists, Inc | |
|
13510 Midlothian Turnpike, Suite B, Midlothian, VA 23113 | |
| (804) 794-4550 | |
| (804) 794-7648 |
| Full Name | Associated Podiatrists, Inc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 13510 Midlothian Turnpike, Midlothian, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487799029 | NPI | - | NPPES |
| 93-0019-8 | Medicaid | VA | |
| 009300198 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 0103000190 (Virginia) | Secondary |
| Provider Name | Neeraj Dinesh Narang |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1619304946 PECOS PAC ID: 4981995750 Enrollment ID: I20160627000099 |
News Archive
Preliminary findings from a pilot study suggest that cognitive behavioral therapy for insomnia may slow or even reverse the atrophy of cortical gray matter in patients who have co-morbid fibromyalgia.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
› Verified 9 days ago
| Provider Name | Anita Patel |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1952698334 PECOS PAC ID: 8729205802 Enrollment ID: I20170118002043 |
News Archive
Preliminary findings from a pilot study suggest that cognitive behavioral therapy for insomnia may slow or even reverse the atrophy of cortical gray matter in patients who have co-morbid fibromyalgia.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Associated Podiatrists, Inc 10801 Tutelo Court, Glen Allen, VA 23059 Ph: (804) 794-4550 | Associated Podiatrists, Inc 13510 Midlothian Turnpike, Suite B, Midlothian, VA 23113 Ph: (804) 794-4550 |
News Archive
Preliminary findings from a pilot study suggest that cognitive behavioral therapy for insomnia may slow or even reverse the atrophy of cortical gray matter in patients who have co-morbid fibromyalgia.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
› Verified 9 days ago
Earnest Foot And Ankle Specialists Plc Podiatrist Medicare: Medicare Enrolled Practice Location: 1336 Alverser Plz, Midlothian, VA 23113 Phone: 804-594-1944 Fax: 804-594-1945 | |
Dr. John G Mcmahon Jr., DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6512 Woodlake Village Cir, Midlothian, VA 23112 Phone: 804-739-6730 Fax: 804-739-6894 | |
Dr. Mark Allen Erdman, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 1336 Alverser Plz, Midlothian, VA 23113 Phone: 804-594-1944 Fax: 804-594-1945 | |
Dr. Alison Milne, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1520 Huguenot Rd, Suite 117, Midlothian, VA 23113 Phone: 804-794-0027 Fax: 804-794-0067 | |
Synergyhealth Foot & Ankle Associates, Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 14349 Justice Rd, Midlothian, VA 23113 Phone: 804-837-4144 Fax: 804-823-9335 | |
Virginia Mobile Wound Care Physicians Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 14512 Standing Oak Ct, Midlothian, VA 23112 Phone: 718-669-6867 |